The influence of hepatitis B infection on the outcome of renal allotransplantation.
Renal allograft and patient survival and liver function abnormalities were studied in a group of HBsAg-negative and -positive recipients. Thirty-five patients were positive, and 20 patients became antigenemic prior to transplantation. Two hundred twenty-four patients were HBsAg-negative. No difference in patient or graft survival was found between patients with hepatitis B antigenemia and antigen-negative cadaver allograft recipients. The incidence of significant hepatic disease was low in comparison with several recently published reports. It is concluded that hepatitis B antigenemia is not an absolute contraindication to transplantation.
D000328:Adult; D002102:Cadaver; D005260:Female; D006085:Graft Survival; D006509:Hepatitis B / Q000150:complications* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D016030:Kidney Transplantation; D008099:Liver / Q000503:physiopathology; D008107:Liver Diseases / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
D006514:Hepatitis B Surface Antigens